SPDL1 and soft tissue sarcoma: High sPD-L1 concentrations were also found to predict future metastases in patients with soft tissue sarcoma (92), and high pretreatment sPD-L1 was associated with an increased likelihood of disease progression in patients with malignant melanoma (65).